Advances of Regulatory B Cells in Autoimmune Diseases

41Citations
Citations of this article
67Readers
Mendeley users who have this article in their library.

Abstract

With the ability to induce T cell activation and elicit humoral responses, B cells are generally considered as effectors of the immune system. However, the emergence of regulatory B cells (Bregs) has given new insight into the role of B cells in immune responses. Bregs exhibit immunosuppressive functions via diverse mechanisms, including the secretion of anti-inflammatory cytokines and direct cell contact. The balance between Bregs and effector B cells is important for the immune tolerance. In this review, we focus on recent advances in the characteristics of Bregs and their functional roles in autoimmunity.

Cite

CITATION STYLE

APA

Zhu, Q., Rui, K., Wang, S., & Tian, J. (2021, April 15). Advances of Regulatory B Cells in Autoimmune Diseases. Frontiers in Immunology. Frontiers Media S.A. https://doi.org/10.3389/fimmu.2021.592914

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free